Results 201 to 210 of about 1,474,812 (347)
Date Range: August 30 \u2013 September 12, 2022Summary of the 2nd COVID-19 Vaccine Summary Report: 6 months through 5 yearsThis report consolidates findings and ways public health partners can act on the findings related to COVID-19 vaccines for children
core
International Journal of Cancer, EarlyView.High‐risk human papillomavirus (hrHPV) testing improves cervical cancer screening by facilitating earlier detection and prevention. In low‐resource settings, however, cost and increased referrals limit its use. At the same time, many new and more affordable assays lack validation.
Neerja Bhatla +28 more
wiley +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective This study conduct viral genome sequencing among severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐infected pregnant and postpartum individuals, and investigates disease severity and maternal and perinatal outcomes considering variant of concern (VOC) and non‐VOC groups.
Guilherme M. Nobrega +27 more
wiley +1 more source
Understanding and explaining viral vector COVID-19 vaccines [PDF]
Several COVID-19 vaccine candidates entering late-stage clinical trials are what is known as viral vector vaccines. These vaccines are likely to be among the COVID-19 vaccines authorized for use in the United States.
core
Engineering Bacteria for Medicine: Delivery, Diagnosis, and Therapy
iMetaMed, EarlyView.ABSTRACT With rapid advances in synthetic biology and genetic engineering, genetically engineered bacteria (GEB) have emerged as a promising platform for biological therapy, addressing key limitations of conventional drug delivery systems and demonstrating significant clinical potential.
Shiyu Xia +11 more
wiley +1 more source
Stay up to date with COVID-19 vaccines [PDF]
What You Need to Know\u2022 CDC recommends the 2023\u20132024 updated COVID-19 vaccines: Pfizer-BioNTech, Moderna, or Novavax, to protect against serious illness from COVID-19.\u2022 Everyone aged 5 years and older \u2021 should get 1 dose of an updated ...
core
Potent monoclonal antibodies against multidrug‐resistant hypervirulent Klebsiella pneumoniae
Interdisciplinary Medicine, EarlyView.A novel immunization strategy using a low‐virulence, multidrug‐resistant strain yields synergistic monoclonal antibodies against hypervirulent Klebsiella pneumoniae. These antibodies provide cross‐serotype protection through a dual‐mechanism of pathogen clearance and immunomodulation, offering a promising non‐antibiotic therapeutic for resistant ...
Yushan Jiang +10 more
wiley +1 more source
RETRACTION: Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis
World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView., 2023 Retraction: Tan, DJY, Ko, TK. Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis. World J Otorhinolaryngol Head Neck Surg. 2023; 1–8. doi:10.1002/wjo2.125. The above article, published online on 28 July 2023 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor ...
Denise Jia Yun Tan, Tsz Ki Ko
wiley +1 more source
Interdisciplinary Medicine, EarlyView.Inspired by the role of Mg2+ in stabilizing RNA secondary structures, we developed a one‐pot biomimetic mineralization method for synthesizing a circular RNA‐based nanovaccine (circRNA@FAiNVac) that integrates formulation and adjuvant functions. This nanovaccine exhibits potent immunostimulatory activation enabling multimodal immune responses and ...
Liangru Lin +10 more
wiley +1 more source